Dorsal Root Ganglion as a Hub for Peripheral Sensitization: A Hierarchical Regulation Model and Translational...

Area of Science:

• Neuroscience
• Pharmacology
• Pain Research

Background:

• High analgesic candidate attrition in clinical trials due to reliance on rodent models and simplified nociception understanding.
• Dorsal root ganglion (DRG) identified as a central hub for peripheral sensitization.

Purpose of the Study:

• Propose a "Hierarchical Regulation Model" to unify fragmented pain sensitization mechanisms.
• Integrate acute, intermediate, and long-term tiers of peripheral sensitization into a systemic framework.
• Address limitations of current analgesic development paradigms.

Main Methods:

• Stratification of peripheral sensitization into three interlocking tiers: acute (ion channels), intermediate (neuroinflammation/glia-immune networks), and long-term (epigenetic reprogramming).
• Analysis of cross-hierarchical feedback loops contributing to pain chronification via "pathological homeostasis."
• Extension of the model to pathology-specific trajectories (e.g., chemotherapy-induced peripheral neuropathy, diabetic peripheral neuropathy).

Main Results:

• The Hierarchical Regulation Model integrates diverse pain mechanisms.
• Pain chronification is linked to "pathological homeostasis" from feedback loops across sensitization tiers.
• Pathology-specific trajectories like "acute layer jumping" and "early metabolic solidification" are identified.

Conclusions:

• Overcoming translational barriers in analgesic development requires a shift from "one-size-fits-all" to precision strategies.
• Precision strategies should be stratified by pathological tier, disease stage, and biological sex.
• The "Human-First" drug development paradigm is validated by recent approvals, such as Suzetrigine (VX-548).